T2 Biosystems brings in $10.8M for diagnostics
T2 Biosystems, a company working to develop new diagnostic methods, received $10.8 million in second-round financing from new investors In-Q-Tel (which also helps fund the CIA, incidentally) and Partners Healthcare, and existing investors Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.
The Cambridge, Mass.-based company plans to use the new money to develop a beta version of a device combining MRI properties and nanotechnology and to run it through a series of tests over the… Continue Reading